Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 30 out of 100. End-of-life care

Topic: Risk, prevention and care in population studies

Plain-language summary

As dementia progresses to advanced stages, the need for compassionate and person-centred care becomes paramount. While institutional settings are often considered default options for palliative and end-of-life care, many individuals with dementia and their families express a strong preference for remaining at home. This presentation will explore the unique challenges and opportunities of providing high-quality palliative care for people with dementia in non-residential environments, drawing from the experience of Mens & Zorg, an award-winning Flemish healthcare company specializing in at-home dementia care. Key themes will include fostering trust with families, addressing complex medical and psychosocial needs, and developing tailored approaches that respect the dignity, autonomy, and preferences of individuals with dementia. The presentation will also highlight strategies for interdisciplinary collaboration and integrating community resources to create a network of support that extends beyond the home. In addition, this session will explore the innovative use of technology and adaptive tools to support caregivers and enhance quality of life during end-of-life stages. Through case studies and qualitative data, the presentation aims to provide practical insights into how person-centred palliative care can empower people with dementia to experience comfort and continuity in the familiarity of their own homes. Key Takeaways: Strategies for delivering holistic, person-centred palliative care in home settings. Tools and resources to support caregivers in managing complex end-of-life needs. Insights from Flemish healthcare models that emphasize dignity, respect, and autonomy. This presentation aims to inspire healthcare professionals, policymakers, and researchers to prioritize home-based palliative care as a viable and humane option for people with dementia.

What this study adds

Evidence grade: Low

This presentation describes the experience of a Flemish healthcare company providing at-home palliative care for people with dementia, covering trust with families, complex needs, and use of technology and community resources. It offers practical insights from case studies and qualitative data on supporting comfort and continuity at home, not a treatment or cure.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Clayton, D. (2025). Home as Haven: Palliative and End‐of‐Life Care for People with Dementia in Non‐Residential Settings. Alzheimer s & Dementia. https://doi.org/10.1002/alz70858_102811

Vancouver

Clayton D. Home as Haven: Palliative and End‐of‐Life Care for People with Dementia in Non‐Residential Settings. Alzheimer s & Dementia. 2025. doi:10.1002/alz70858_102811. PMID: 41450024.

BibTeX

@article{clayton2025-41450024,
  author  = {Clayton, Dáithí},
  title   = {{Home as Haven: Palliative and End‐of‐Life Care for People with Dementia in Non‐Residential Settings}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70858_102811},
  pmid    = {41450024},
  url     = {https://doi.org/10.1002/alz70858_102811}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This presentation describes the experience of a Flemish healthcare company providing at-home palliative care for people with dementia, covering trust with families, complex needs, and use of technology and community resources. It offers practical insights from case studies and qualitative data on supporting comfort and continuity at home, not a treatment or cure.

Study details

How this study scored 30/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record left out, no data; Multicenter collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. 28 of the 93 points it could be judged on, which is 30 of 100. Total 30 of 100.28 of the 93 points we could judge = 30 of 100

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record and institution's track record, so those were left out: it earned 28 of the 93 points we could judge it on, which is 30 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 3 year(s) since 2025
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author Dáithí Clayton holds only 3 work(s), too few to judge a track record — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multicenter collaboration 0 / 3 OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41450024)
Free to read 2 / 2 Free to read
Points 28 / 93 Scored on 18 of 20 parts. We have no data for the rest, so they are left out: 28 of the 93 points we could judge it on is 30 out of 100.
Total 30 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in End-of-life care from nearby years

Also tagged “nursing”

995 studies in the library carry the topic tag “nursing”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 995 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on End-of-life care

See all studies in End-of-life care →